Usage: Adakveo reduces the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease.
Usage: Casgevy is used to treat patients aged 2 and older with sickle cell disease (SCD) that causes recurring pain crises, or transfusion-dependent beta-thalassemia (TDT), a condition requiring regular blood transfusions.